Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Canadian Liver Journal|February 23, 2026
Barriers and facilitators to liver fibrosis screening: Perspectives and practices of Canadian primary care physiciansDuy A Dinh, Michael Betel, Mark Swain, et al.
Diabetes, Obesity & Metabolism|November 18, 2018
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetesKenneth Cusi, Fernando Bril, Diana Barb, et al.
Journal of Hepatology|November 8, 2019
Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb studyStephen A Harrison, Naim Alkhouri, Beth A Davison, et al.
Contemporary Clinical Trials|July 24, 2017
Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH studyA S Barritt, Norman Gitlin, Samuel Klein, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 15, 2022
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world CohortArun J Sanyal, Breda Munoz, Kenneth Cusi, et al.
Obesity (Silver Spring, Md.)|May 23, 2019
Neurocognitive Deficits in a Cohort With Class 2 and Class 3 Obesity: Contributions of Type 2 Diabetes and Other ComorbiditiesHeshan J Fernando, Ronald A Cohen, Joseph M Gullett, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 11, 2018
Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitisSrilaxmi Kalavalapalli, Fernando Bril, Jeremy P Koelmel, et al.
Metabolism: Clinical and Experimental|July 22, 2021
Preparing for the NASH epidemic: A call to actionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Pageof 19